Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 8/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | GLA | P06280 | 6/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.59 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15745909 | 0.83 | MIF (0.71) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL15842472 | 0.83 | MIF (0.71) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL6379547 | 0.83 | HSD17B3 (0.68) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL24715090 | 0.80 | MIF (0.67) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL29943964 | 0.80 | MIF (0.67) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL9635601 | 0.80 | MIF (0.67) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL15842406 | 0.78 | GPR35 (0.65) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL622794 | 0.77 | KDM4E (0.64) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL5296804 | 0.77 | HSD17B3 (0.68) | MIFCA9MEN1GLAKMT2A | |
| SCHEMBL1094715 | 0.76 | GLA (1.00) | MIFCA9MEN1GLAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118843334-A | Perovskite solar cell, preparation method thereof and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-10-25 | — | — | CN | claimed |
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-23 | — | — | US | claimed |
| EP-3377897-B1 | LACTATE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377898-B1 | THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377904-B1 | UREA BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117630356-A | Method and reagent for detecting bacterial vesicle | 南方医科大学南方医院 | 2024-03-01 | — | — | CN | claimed |
| CN-112322715-B | Nucleic acid sequencing method | 清华大学 | 2022-11-25 | — | — | CN | claimed |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2022-08-04 | — | — | US | claimed |
| WO-2022105640-A1 | NUCLEIC ACID SEQUENCING METHOD | 清华大学 | 2022-05-27 | — | — | WO | claimed |
| EP-3997462-A1 | ASSAYS FOR IMPROVING AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING ACCURACY | Selux Diagnostics Inc. (US) | 2022-05-18 | — | — | EP | claimed |
| WO-2012168415-A1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | BIOSYNTH AG (CH) | 2012-12-13 | — | — | WO | claimed |
| EP-2532753-A1 | Method for detection of beta-D-glucuronidase | Biosynth AG (CH) | 2012-12-12 | — | — | EP | claimed |
| EP-2516666-A1 | METHODS OF DETECTING MICROORGANISMS AND KITS THEREFORE | 3M Innovative Properties Company (US) | 2012-10-31 | — | — | EP | claimed |
| US-20120252049-A1 | METHODS OF DETECTING MICROORGANISMS AND KITS THEREFORE | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-04 | — | — | US | claimed |
| WO-2011087711-A1 | METHODS OF DETECTING MICROORGANISMS AND KITS THEREFORE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-07-21 | — | — | WO | claimed |
| US-20100038632-A1 | ELECTROLUMINESCENT DEVICE | OLED-T LIMITED (GB) | 2010-02-18 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| WO-1993016064-A1 | COUMARIN DERIVATIVES AND THEIR ANALOGUES INHIBITING CELL PROLIFERATION AND TUMOUR GROWTH, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | BIOSIGNAL, Kutató-Fejleszto^' Kft. (HU) | 1993-08-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MIF 3154/4885CA9 185/4885MEN1 2391/4885 |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MIF 3154/4885CA9 185/4885MEN1 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.